Evidence map›Paper›PMID 36247831›Full record

ArticleNeurology and clinical neuroscience2022

Acute psychosis post-COVID-19 pneumonia.

Odai Abdalla, Emma Oskar, Shahram Izadyar

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Neurology and clinical neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Novel Advancements in COVID-19 and Neuroscience.Journal of personalized medicine · 2024
    Article
  2. Acute psychosis post-COVID-19 pneumonia.Neurology and clinical neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Odai AbdallaDepartment of Neurology SUNY Upstate Medical University Syracuse New York USA.ORCID https://orcid.org/0000-0003-3473-1015
Emma OskarNorton College of Medicine SUNY Upstate Medical University Irving New York USA.
Shahram IzadyarDepartment of Neurology SUNY Upstate Medical University Syracuse New York USA.
SUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 disease can be associated with several health-related consequences that are directly or indirectly related to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute psychiatric illnesses in the setting of COVID-19 infection are one of the reported consequences. In this case report, we discuss acute onset of psychosis in a young patient that we believe was related to post-COVID-19 infection. Some findings in the EEG in this patient, we believe, were related to use of antipsychotic medications and that caused challenges in the diagnosis. It is important to be aware of post-COVID-19 psychosis and challenges that may be encountered in the workup.

Indexed as

acute psychosisantipsychotic medicationCOVID‐19 diseaseepilepsypneumonia

Identifiers

PMID36247831
PMCPMC9537979
OpenAlexW4296130276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.